Was Tennis Star Novak Djokovic’s Media Coverage in Australia All a Show to Promote his New Biotech Pharmaceutical Company?

I have never really been a fan of tennis, but like many in the Alternative Media, I watched the saga unfold in Australia recently with the world's number 1 professional tennis star, Serbian Novak Djokovic, who ended up not being able to defend his title in the Australian Open, allegedly due to his stance against the mandates for the COVID-19 shots. Due to his position against mandated COVID-19 shots, and the alleged trouble he was having in Australia, his name was in my news feed non-stop for many days, with the result that he gained international fame not only among tennis fans who already knew him due to his superstar status as a tennis player, but also among the "anti-vaxxers" crowd where he instantaneously achieved "superstar" status as well, even if people had never heard of him before because they don't follow tennis. I have to admit that I was considering publishing a story about his saga myself here on the Health Impact News network, but as the story unfolded it got stranger, and the longer it dragged on, the more the Alternative Media continued publishing stories about him, portraying him as a victim of "the mandates." So as his press coverage increased, I decided to take a pass on his story, since it was already getting so much coverage in the Alternative Media, and something just didn't seem right to me about the whole thing. It just seemed that whatever the real issue was, it could have been dealt with one way or another very quickly, even before he arrived, or stopped him from going there altogether. Then yesterday, January 19, 2022, ZeroHedge News published a report on Novak Djokovic revealing that he "owns 80% stake in a Biotech firm working on COVID cure," based on a Reuter's story. Djokovic earns more income outside of tennis than he does as a professional tennis player, so it would make sense that he could have potentially given up his chance at defending his title at the Australian Open to be able to cash in on a larger financial windfall down the road for his drug company, by capitalizing on his stance against the mandates for COVID-19 shots.